Menu
GWAS Study

Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients.

Weizman A, Huang B, Berel D et al.

24487271 PubMed ID
GWAS Study Type
5756 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WA
Weizman A
HB
Huang B
BD
Berel D
TS
Targan SR
DM
Dubinsky M
FP
Fleshner P
IA
Ippoliti A
KM
Kaur M
PD
Panikkath D
BS
Brant S
OI
Oikonomou I
DR
Duerr R
RJ
Rioux J
SM
Silverberg M
RJ
Rotter JI
VE
Vasiliauskas E
HT
Haritunians T
SD
Shih D
LD
Li D
MG
Melmed GY
MD
McGovern DP
Chapter II

Abstract

Summary of the research findings

Pyoderma gangrenosum (PG) and erythema nodosum (EN) are the most common cutaneous manifestations of inflammatory bowel disease (IBD) but little is known regarding their etiopathogenesis.

92 European ancestry cases, 5,664 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

5756
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.